Inexios Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2006.
2006 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Inexios Pharmaceuticals Private Limited

Inexios Pharmaceuticals Private Limited, a active private limited company, was established on 23 November 2006 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the real estate sector, it holds CIN: U24232KA2006PTC041018. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Its leadership includes Rajesh Srivathsa (Director), Nandan Laxman Sastry (Director), Sriram Chakravarti (Director). Past directors included Sriram Nadathur, Nadathur Srinivasa Raghavan, Sarangarajan Varadachari. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Nadathur Place, 3Rd Floor, Plot No. 23 8Th Main Road, Jayanagar 3Rd Block, Bangalore, Karnataka, 560011.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232KA2006PTC041018

  • Registration Number

    041018

  • Incorporation Date

    23 November 2006

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 19 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 10.71%
  • Profit Growth **** 14.29%
  • Ebitda **** -4.70%
  • Net Worth 1.66%
  • Total Assets **** 1.78%
Company report

Inexios Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Inexios Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Inexios Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajesh Srivathsa Director 16 Apr 2018 Current
Nandan Laxman Sastry Director 16 Mar 2015 Current
Sriram Chakravarti Director 20 Sep 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 16 Mar 2015 Past
Pramod Abcsdd Director 16 Mar 2015 Past
Pramod Abcsdd Additional Director 29 Sep 2011 Past
Pramod Abcsdd Additional Director 26 Dec 2007 Past
Pramod Abcsdd Additional Director 14 Sep 2018 Past
Pramod Abcsdd Director 03 Mar 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Inexios Pharmaceuticals.

Inexios Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.71% increase. The company also saw a substantial improvement in profitability, with a 14.29% increase in profit. The company's net worth moved up by a moderate rise of 1.66%.

Inexios Pharmaceuticals revenue growth over time
Inexios Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 10.71%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 1.78%
*******
*******
*******
*******
Profit or Loss
*******
 14.29%
*******
*******
*******
*******
Net Worth
*******
 1.66%
*******
*******
*******
*******
EBITDA
*******
 -4.70%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Inexios Pharmaceuticals?

Unlock access to Inexios Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Inexios Pharmaceuticals?

Inexios Pharmaceuticals has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Inexios Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inexios Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Inexios Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Inexios Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Inexios Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was completed.

  • Director Appointment

    Progress on Sriram Chakravarti was appointed as a Director was appointed as a Director on 20 Sep 2021 & has been associated with this company since 4 years 4 months . was documented.

  • Director Appointment

    Rajesh Srivathsa was appointed as a Director was appointed as a Director on 16 Apr 2018 & has been associated with this company since 7 years 9 months . was recorded as a recent event.

  • Director Appointment

    The activity Nandan Laxman Sastry was appointed as a Director was appointed as a Director on 16 Mar 2015 & has been associated with this company since 10 years 11 months . was completed.

  • Company Incorporation

    Progress on Inexios Pharmaceuticals Private Limited was registered on 23 Nov 2006 with Roc Bangalore & aged 19 years 2 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Inexios Pharmaceuticals Private Limited?

The CIN of Inexios Pharmaceuticals Private Limited is U24232KA2006PTC041018.

Where is Inexios Pharmaceuticals Private Limited headquartered?

Inexios Pharmaceuticals Private Limited is headquartered at Nadathur Place, 3Rd Floor, Plot No. 23 8Th Main Road, Jayanagar 3Rd Block, Bangalore, Karnataka, 560011.

When was Inexios Pharmaceuticals Private Limited incorporated?

Inexios Pharmaceuticals Private Limited was incorporated on 23 November 2006.

Who are the current directors of Inexios Pharmaceuticals Private Limited?

The current directors of Inexios Pharmaceuticals Private Limited are

What is the primary industry of Inexios Pharmaceuticals Private Limited?

The primary industry of Inexios Pharmaceuticals Private Limited is Real Estate.

Is Inexios Pharmaceuticals Private Limited a listed company?

Inexios Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Inexios Pharmaceuticals Private Limited?

The authorized capital of Inexios Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Inexios Pharmaceuticals Private Limited?

The compliance status of Inexios Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available